Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01419847 · ClinicalTrials.gov registry record · Phase 4
Topical Penlac Nail Lacquer for Onychomycosis in Children
A Phase 4 study, sponsored by Rady Children's Hospital, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01419847 is a Phase 4 study that has completed, run by Rady Children's Hospital, San Diego. The registered enrollment target is 40 participants.
The verdict
NCT01419847, a Phase 4 study, has completed, sponsored by Rady Children's Hospital, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
Five months of therapy is sufficient to treat onychomycosis in children. Topical therapy of onychomycosis in children with Penlac nail lacquer has comparable efficacy and a superior cost and safety profile compared to systemic therapy.
Interventions
- DRUG Placebo
- DRUG Ciclopirox
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2002-03 |
| Est. Completion | 2006-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01419847
The ClinicalTrials.gov registry entry for NCT01419847 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rady Children's Hospital, San Diego, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01419847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01419847 about?
NCT01419847 is a clinical study titled "Topical Penlac Nail Lacquer for Onychomycosis in Children". Five months of therapy is sufficient to treat onychomycosis in children. Topical therapy of onychomycosis in children with Penlac nail lacquer has comparable efficacy and a superior cost and safety profile compared to systemic therapy.
What is the current status of trial NCT01419847?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2002-03. Estimated completion is 2006-05.
What interventions are being tested in trial NCT01419847?
The interventions under investigation include: Placebo (DRUG), Ciclopirox (DRUG).
Who is sponsoring clinical trial NCT01419847?
This trial is sponsored by Rady Children's Hospital, San Diego, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.